Quinapril
- Product NDC
- 70934-582
- 11-digit product format
- 709340582
- Labeler code
- 70934
- Product ID
- 70934-582_abab5ebc-bb3d-987f-e053-2995a90a6209
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Quinapril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA077690
- Marketing category
- ANDA
- Marketing start
- 2020-02-26
- Marketing end
- 0000-00-00
- Substance
- QUINAPRIL HYDROCHLORIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 33067B3N2M | QUINAPRIL HYDROCHLORIDE | 82586-55-8 | QUINAPRIL HYDROCHLORIDE |
| RJ84Y44811 | QUINAPRIL | 85441-61-8 | Quinapril |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-582-30 | 70934058230 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-582-30) | 30 tablet | 2020-02-26 | 0000-00-00 | No | No | Current |